General Information of Drug Inactive Ingredient (DIG) (ID: E00410)

DIG Name
Erythritol
Synonyms
ERYTHRITOL; meso-Erythritol; 149-32-6; Phycitol; Erythrit; Phycite; Erythrol; (2R,3S)-butane-1,2,3,4-tetrol; erythro-tetritol; 1,2,3,4-Butanetetrol, (2R,3S)-rel-; Mesoerythritol; Erythrite; L-Erythritol; i-Erythritol; Erythritol [NF]; MFCD00004710; UNII-RA96B954X6; CHEBI:17113; meso-1,2,3,4-Tetrahydroxybutane; Erythritol, meso-; Erythritol,meso-erythritol; Antierythrite; Butanetetrol; Paycite; 1,2,3,4-Butanetetrol; C*Eridex; NSC8099; Erythritol (NF); RA96B954X6; Erythrol (VAN); (2r,3s)-butane-1,2,3,4-tetraol; (2S,3R)-butane-1,2,3,4-tetrol; meso-Erythritol, 99%; rel-(2R,3S)-butane-1,2,3,4-tetraol; NIK 242; NSC 8099; MRY; SMR000112220; C4H10O4; CCRIS 7901; HSDB 7968; 1,2,3,4-Butanetetrol, (theta,S)-; EINECS 205-737-3; D-ERYTHRITOL; E968; WLN: Q1YQYQ1Q; 1,3,4-Tetrahydroxybutane; Epitope ID:114707; meso-Erythritol, >=99%; DSSTox_CID_23919; DSSTox_RID_80090; DSSTox_GSID_43919; SCHEMBL17062; 10030-58-7; MLS001332365; MLS001332366; CHEMBL349605; DTXSID6043919; HMS2270M08; Pharmakon1600-01301025; NSC-8099; meso-Erythritol, analytical standard; Tox21_200564; NSC760400; s4224; ZINC17971067; 1,3,4-Butanetetrol, (R*,S*)-; AKOS006339851; AM83963; CCG-266079; DB04481; DS-5851; EBD2197995; NSC-760400; NCGC00247033-01; NCGC00258118-01; CAS-149-32-6; E0021; SW219107-1; W1905; A-9333; C00503; D08915; WURCS=2.0/1,1,0/[h22h]/1/; 134866-EP2292597A1; 134866-EP2292612A2; 134866-EP2371811A2; 134866-EP2377849A2; 149E326; Q421873; F0001-2636; BDF1567C-B08B-425A-B87F-15FF46328423; Erythritol, European Pharmacopoeia (EP) Reference Standard; Erythritol, United States Pharmacopeia (USP) Reference Standard; Erythritol, Pharmaceutical Secondary Standard; Certified Reference Material
DIG Function
Diluent; Flavoring agent
Formula
C4H10O4
Canonical SMILES
C([C@H]([C@H](CO)O)O)O
InChI
1S/C4H10O4/c5-1-3(7)4(8)2-6/h3-8H,1-2H2/t3-,4+
InChIKey
UNXHWFMMPAWVPI-ZXZARUISSA-N
Physicochemical Properties Molecular Weight 122.12 Topological Polar Surface Area 80.9
XlogP -2.3 Complexity 48
Heavy Atom Count 8 Rotatable Bond Count 3
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 4

Full List of Drug(s) Co-administrated with This DIG

1 Approved Drug(s) Co-administrated with This DIG
Drug Name Drug ID Indication Formulation Name Formulation ID
Meclizine DMS7T13 Dizziness [MB48] Meclizine 25 mg tablet F12764
------------------